Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020

Author: Keita Morikane ¹ ; Naohito Satoh ¹ ; Kanji Hatano ¹ ; Kazunori Kanouchi ¹ ; Seiji Kakehata ¹ ; Shinya Satoh ¹ ; Timothy Uyeki ² ; Yoshiyuki Ueno ¹
Author Information

1. Yamagata University, Yamagata, Japan
2. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Publication Type:Journal Article
From: Western Pacific Surveillance and Response 2021;12(1):69-71
CountryWHO-WPRO
Language:English
Abstract: We conducted a seroepidemiological study in a northern Japanese prefecture where the incidence of identified COVID-19 cases was low. In June 2020, residual sera from 1009 outpatients were tested for antibody to SARS-CoV-2 by electrochemiluminescence immunoassay. Five specimens (0.5%) tested positive, suggesting low prevalence of SARS-CoV-2 infections in this population.
Full text:wpsar.2020.11.3.012 Morikane - FINAL.v2.pdf